Otonomy Announces Pricing of $30.1 Million Public Offering

Back to Jobs

SAN DIEGO , April 07, 2021 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the pricing of an underwritten public offering of 6,288,890 shares of its common stock at a price to the

Apply Now